Ixabepilone

Clinical Journal of Oncology Nursing
Alisha Stein

Abstract

Patterns of breast cancer care continue to be amended because of the more frequent use of anthracyclines and taxanes in earlier lines of therapy (particularly in the adjuvant setting) and the emergence of multidrug resistance. When treating women with recurrent or metastatic breast cancer that is resistant to anthracyclines and taxanes, nurses have a unique opportunity to foster a sense of hope by helping patients understand available treatment options and what to expect during therapy. This article presents information on the use of an epothilone agent, ixabepilone (Ixempra, Bristol-Myers Squibb), a new treatment option for metastatic breast cancer after anthracycline and taxane failure. The information will allow nurses and their patients to collaborate as a team to help prevent or effectively manage side effects. In addition, nurses can take a proactive approach in educating patients about treatment options to enhance their quality of life.

References

Oct 1, 1998·The New England Journal of Medicine·G N Hortobagyi
May 2, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jame AbrahamTito Fojo
Jul 26, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P ReichardtH J Lück
Aug 9, 2003·Expert Opinion on Drug Safety·Maurie Markman
Feb 14, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P FumoleauM Namer
May 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan GoodinEric H Rubin
Sep 3, 2004·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Hilde MarséSonia Valverde
Jan 11, 2005·The Journal of Pathology·D B Longley, P G Johnston
Mar 11, 2005·Oncology Nursing Forum·Terri ArmstrongMark R Gilbert
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer A LowSandra M Swain
Nov 23, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric H RubinAmit M Oza
Apr 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James J Lee, Sandra M Swain
May 2, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James J LeeSandra M Swain
Aug 8, 2006·Seminars in Oncology·Eric K Rowinsky, Emiliano Calvo
Mar 3, 2007·The Lancet Oncology·Susan CleatorR Charles Coombes
Apr 5, 2007·The Oncologist·Javier Cortes, Jose Baselga
Jul 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Luca Gianni
Jul 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neelima DenduluriSandra M Swain
Jul 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henri RochéHervé Curé
Jul 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edith A PerezGabriel N Hortobagyi
Jul 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eva ThomasMiguel Martin
Oct 31, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eva S ThomasHenri H Roché
Jan 25, 2008·Briefings in Functional Genomics & Proteomics·José E Pérez-Ortín
Mar 20, 2008·Cancer Chemotherapy and Pharmacology·Francis Y F LeeRobert Kramer
Apr 22, 2008·Addiction Biology·María E QuintanillaLutske Tampier
Jul 17, 2008·Nucleic Acids Research·Daniel J WeisenbergerPeter W Laird
Aug 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eleni Andreopoulou, Gabriel N Hortobagyi
Jan 28, 2009·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Laura Boehnke Michaud
Nov 3, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P SchmidD Kühnhardt

❮ Previous
Next ❯

Citations

Feb 20, 2015·Journal of the National Cancer Institute·Angela Broggini-TenzerMartin Pruschy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.